Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:402-404

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Force, T.
Right arrow Articles by Michael, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Force, T.
Right arrow Articles by Michael, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PHENYLEPHRINE

(Circulation. 2002;105:402.)
© 2002 American Heart Association, Inc.


Editorials

Apoptosis Signal-Regulating Kinase/Nuclear Factor-{kappa}B

A Novel Signaling Pathway Regulates Cardiomyocyte Hypertrophy

Thomas Force, MD; Syed Haq, MD; Heiko Kilter, MD; Ashour Michael, PhD

From the Molecular Cardiology Research Institute, New England Medical Center and the Department of Medicine, Tufts University School of Medicine, Boston, Mass.

Correspondence to Thomas Force, MD, Molecular Cardiology Research Institute, New England Medical Center, 750 Washington St, Box 8486, Boston, MA 02111. E-mail tforce@lifespan.org


Key Words: Editorials • angiotensin • heart failure • signal transduction • oxidant stress

Since 1993, when Sadoshima et al1 published their observations on the role of Angiotensin II (Ang II) in the stretch-induced hypertrophic response of cardiomyocytes, we have known that peptide hormones were important in the development of hypertrophy stimulated by cell stretch, the initiating stimulus in pressure overload-induced hypertrophy and in the hypertrophy that occurs in the noninfarcted myocardium following a myocardial infarction. Ang II, as well as endothelin-1 (ET-1) and {alpha}-adrenergic agents, activate intracellular pathways by binding to 7 transmembrane-spanning receptors coupled to heterotrimeric G proteins of the Gq class. The critical role of this class of receptors and G proteins in pressure overload-induced hypertrophy was elegantly demonstrated by Ahkter et al2 who showed that cardiac specific expression in mice of a peptide that blocked signal transmission by Gq markedly blunted the hypertrophic response to aortic banding.

See p 509

The question that has dominated the field of cardiomyocyte biology is how do these hormones, acting via their cognate receptors and Gq, trigger the hypertrophic response? One clear conclusion has evolved thus far: the hypertrophic response of cardiomyocytes is regulated by an enormously complex network of interacting cytosolic signaling pathways.3 Gq activation ultimately results in the production of intermediates that increase cytosolic free [Ca2+] and activate members of the protein kinase C family, and leads to the recruitment of several protein kinases, including the mitogen-activated protein kinases (MAPKs), calcium calmodulin-dependent protein kinases, Akt/PKB, and the Janus kinases. These kinases phosphorylate a number of transcription factors, increasing their transcriptional activating . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Chao, Y. Shen, L. Li, H. Zhao, S. E. Meiler, S. A. Cook, and A. Rosenzweig
Fas-associated death-domain protein inhibits TNF-{alpha} mediated NF-{kappa}B activation in cardiomyocytes
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2073 - H2080.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Tsujimoto, S. Hikoso, O. Yamaguchi, K. Kashiwase, A. Nakai, T. Takeda, T. Watanabe, M. Taniike, Y. Matsumura, K. Nishida, et al.
The Antioxidant Edaravone Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy
Hypertension, May 1, 2005; 45(5): 921 - 926.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Planavila, J. C. Laguna, and M. Vazquez-Carrera
Nuclear Factor-{kappa}B Activation Leads to Down-regulation of Fatty Acid Oxidation during Cardiac Hypertrophy
J. Biol. Chem., April 29, 2005; 280(17): 17464 - 17471.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Goren, J. Cuenca, P. Martin-Sanz, and L. Bosca
Attenuation of NF-{kappa}B signalling in rat cardiomyocytes at birth restricts the induction of inflammatory genes
Cardiovasc Res, November 1, 2004; 64(2): 289 - 297.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. A. Cook, M. S. Novikov, Y. Ahn, T. Matsui, and A. Rosenzweig
A20 Is Dynamically Regulated in the Heart and Inhibits the Hypertrophic Response
Circulation, August 12, 2003; 108(6): 664 - 667.
[Abstract] [Full Text] [PDF]